Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)

Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Struktur
257277-58-0
CAS-Nr.
257277-58-0
Englisch Name:
Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
Synonyma:
Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
CBNumber:
CB113103513
Summenformel:
C51H61N8O9P
Molgewicht:
961.05
MOL-Datei:
257277-58-0.mol

Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Eigenschaften

pka
7.87±0.43(Predicted)

Sicherheit

Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd. 13771642864
snhuyu_2008@126.com China 1107 58

  • Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[2-[(dimethylamino)oxy]ethyl]-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
  • 257277-58-0
Copyright 2019 © ChemicalBook. All rights reserved